Literature DB >> 26459972

Viruses that ride on the coat-tails of actin nucleation.

Timothy P Newsome1, N Bishara Marzook2.   

Abstract

Actin nucleation drives a diversity of critical cellular processes and the motility of a select group of viral pathogens. Vaccinia virus and baculovirus, Autographa californica multiple nucleopolyhedrovirus, recruit and activate the cellular actin nucleator, the Arp2/3 complex, at the surface of virus particles thereby instigating highly localized actin nucleation. The extension of these filaments provides a mechanical force that bestows the ability to navigate the intracellular environment and promote their infectious cycles. This review outlines the viral and cellular proteins that initiate and regulate the signalling networks leading to viral modification of the actin cytoskeleton and summarizes recent insights into the role of actin-based virus transport.
Copyright © 2015. Published by Elsevier Ltd.

Entities:  

Keywords:  Actin; Arp2/3 complex; Baculovirus; Cytoskeleton; Microtubules; N-WASP; Vaccinia; Virus transport

Mesh:

Substances:

Year:  2015        PMID: 26459972     DOI: 10.1016/j.semcdb.2015.10.008

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  14 in total

1.  Tagging of the vaccinia virus protein F13 with mCherry causes aberrant virion morphogenesis.

Authors:  David C J Carpentier; Michael S Hollinshead; Helen A Ewles; Stacey-Ann Lee; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2017-10       Impact factor: 3.891

2.  A novel host factor for human respiratory syncytial virus.

Authors:  Masfique Mehedi; Peter L Collins; Ursula J Buchholz
Journal:  Commun Integr Biol       Date:  2017-05-08

3.  Vaccinia virus proteins A36 and F12/E2 show strong preferences for different kinesin light chain isoforms.

Authors:  William N D Gao; David C J Carpentier; Helen A Ewles; Stacey-Ann Lee; Geoffrey L Smith
Journal:  Traffic       Date:  2017-06-27       Impact factor: 6.215

4.  Loss of Actin-Based Motility Impairs Ectromelia Virus Release In Vitro but Is Not Critical to Spread In Vivo.

Authors:  Melanie Laura Duncan; Jacquelyn Horsington; Preethi Eldi; Zahrah Al Rumaih; Gunasegaran Karupiah; Timothy P Newsome
Journal:  Viruses       Date:  2018-03-05       Impact factor: 5.048

5.  Ebola Virus Nucleocapsid-Like Structures Utilize Arp2/3 Signaling for Intracellular Long-Distance Transport.

Authors:  Katharina Grikscheit; Olga Dolnik; Yuki Takamatsu; Ana Raquel Pereira; Stephan Becker
Journal:  Cells       Date:  2020-07-19       Impact factor: 6.600

6.  The eukaryotic translation elongation factor 1A regulation of actin stress fibers is important for infectious RSV production.

Authors:  Natale Snape; Dongsheng Li; Ting Wei; Hongping Jin; Mary Lor; Daniel J Rawle; Kirsten M Spann; David Harrich
Journal:  Virol J       Date:  2018-11-26       Impact factor: 4.099

Review 7.  The mechanics of malaria parasite invasion of the human erythrocyte - towards a reassessment of the host cell contribution.

Authors:  Marion Koch; Jake Baum
Journal:  Cell Microbiol       Date:  2016-01-11       Impact factor: 3.715

8.  Vaccinia virus egress mediated by virus protein A36 is reliant on the F12 protein.

Authors:  David C J Carpentier; Alexander Van Loggerenberg; Nele M G Dieckmann; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2017-06-20       Impact factor: 3.891

9.  Phototracking Vaccinia Virus Transport Reveals Dynamics of Cytoplasmic Dispersal and a Requirement for A36R and F12L for Exit from the Site of Wrapping.

Authors:  Helena Lynn; Liam M Howell; Russell J Diefenbach; Timothy P Newsome
Journal:  Viruses       Date:  2018-07-24       Impact factor: 5.048

10.  Ectromelia virus induces tubulin cytoskeletal rearrangement in immune cells accompanied by a loss of the microtubule organizing center and increased α-tubulin acetylation.

Authors:  Lidia Szulc-Dąbrowska; Mateusz Palusiński; Justyna Struzik; Karolina P Gregorczyk-Zboroch; Felix N Toka; Ada Schollenberger; Małgorzata Gieryńska
Journal:  Arch Virol       Date:  2018-10-29       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.